Clinical Trials on Primary Myelofibrosis (MF)
Total 59447 results
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
The University of Hong KongNovartisRecruitingPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic StageHong Kong
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Keros Therapeutics, Inc.IQVIA BiotechRecruitingMyelofibrosisAustralia
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States, Korea, Republic of, Spain, France, Italy, Israel, Canada, Romania
-
University of MichiganNational Cancer Institute (NCI); SanofiRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
AbbVieCompletedMyelofibrosisArgentina, Australia, Brazil, Canada, Colombia, Greece, Italy, Mexico, Poland, Portugal, Romania, Taiwan, Turkey, United States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
John MascarenhasCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedMyelofibrosisUnited Kingdom, Germany, Canada, Singapore, Netherlands, Italy, Australia, France
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Margherita MaffioliUnknown
-
University Hospital, BrestCompleted
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCTerminated
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Myeloproliferative...CompletedMyelofibrosisUnited States, Canada, Italy, Sweden
-
Weill Medical College of Cornell UniversityCompleted
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; Second Affiliated... and other collaboratorsRecruiting
-
University Hospital, AngersNot yet recruiting
-
Bristol-Myers SquibbRecruiting
-
The University of Hong KongImago BioSciences,Inc.Recruiting
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Institutes of Health (NIH); National...RecruitingMyelofibrosisUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedMyelofibrosisChina
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCTI BioPharma; Dutch Cancer SocietyActive, not recruitingMyelofibrosisNetherlands, Belgium
-
Qilu Hospital of Shandong UniversityCompleted
-
Geron CorporationCompletedMyelofibrosisUnited States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany
-
Hoffmann-La RocheCompletedMyelofibrosisItaly, United States, Canada, Germany
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of UtahM.D. Anderson Cancer Center; Baylor College of Medicine; Fred Hutchinson Cancer...Completed
-
Cellenkos, Inc.Recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
French Innovative Leukemia OrganisationCompleted
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
Actuate Therapeutics Inc.Completed